AbCellera Biologics (ABCL) PT Raised to $12 at Truist Securities
Tweet Send to a Friend
(Updated - May 22, 2026 9:20 AM EDT)
Truist Securities analyst Srikripa Devarakonda raised the price target on AbCellera ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Truist Securities analyst Srikripa Devarakonda raised the price target on AbCellera ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
